Form 4: Guardant Health Executive Darya Chudova Reports Stock Transactions
SEC Form 4 Filing
Darya Chudova, Chief Technology Officer of Guardant Health, reports the vesting of restricted stock units and subsequent share transactions to cover tax obligations.
Summary
- Darya Chudova, Chief Technology Officer of Guardant Health, filed a Form 4 detailing changes in beneficial ownership.
- On May 15, 2024, 8,705 shares of common stock were acquired through the vesting of restricted stock units.
- Also on May 15, 2024, 3,106 shares were disposed of to cover tax withholding obligations at a price of $25.75 per share.
- Following these transactions, Chudova directly owns 43,000 shares of Guardant Health common stock and 26,116 restricted stock units.
- The restricted stock units were granted on August 7, 2023, and vest over a four-year period.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing stock transactions, indicating a neutral sentiment.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. This filing indicates standard compensation practices and tax obligation fulfillment.
Key Dates
| Date | Description |
|---|---|
| 08/07/2023 | Date of restricted stock unit award grant |
| 05/14/2024 | Date of shares acquired under Guardant Health's Employee Stock Purchase Plan |
| 05/15/2023 | One-year anniversary of vesting start date for restricted stock units |
| 05/15/2024 | Date of stock transactions (vesting and tax withholding) |
| 05/16/2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.